Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paul Cathcart

The Management Impact of 68gallium-Tris(hydroxypyridinone) Prostate-Specific Membrane Antigen (68Ga-THP-Psma) PET-CT Imaging for High-Risk and Biochemically Recurrent Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging

English

Related publications

Erratum To: Repeatability of [68Ga]DKFZ11-Psma PET Scans for Detecting Prostate-Specific Membrane Antigen-Positive Prostate Cancer

Molecular Imaging and Biology

English

Impact of 68Ga-Psma-Pet/Ct on the Radiotherapeutic Approach for Prostate Cancer in Comparison to CT – A Retrospective Analysis

Journal of Nuclear Medicine

English

Mp36-02 Diagnostic Value of 68 Ga-Labelled Prostate-Specific Membrane Antigen (Psma) Pet/Ct Imaging for Renal Cell Carcinoma

Journal of Urology

Urology

2018

English

PET Imaging of Prostate Cancer Xenografts With a Highly Specific Antibody Against the Prostate-Specific Membrane Antigen

Journal of Nuclear Medicine

English

68Ga-Psma Ligand PET/CT in Patients With Prostate Cancer: How We Review and Report

Cancer Imaging

Nuclear Medicine

Radiology

Ultrasound Technology

English

Comparison of 68Ga-Psma-11 PET/CT With 11c-Acetate PET/CT in Re-Staging of Prostate Cancer Relapse

Scientific Reports

Multidisciplinary

2020

English

Correction To: Randomized Prospective Phase III Trial of 68Ga-Psma-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]

English

Diagnostic Accuracy of 68Ga-Prostate-Specific Membrane Antigen (PSMA) Positron-Emission Tomography (PET) and Multiparametric (Mp)MRI to Detect Intermediate-Grade Intra-Prostatic Prostate Cancer Using Whole-Mount Pathology: Impact of the Addition of 68Ga-P

BJU International

Urology

2019

English

Diagnostic Performance of 68Ga-Psma-11 (HBED-CC) PET/CT in Patients With Recurrent Prostate Cancer: Evaluation in 1007 Patients

European Journal of Nuclear Medicine and Molecular Imaging

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Paul Cathcart

The Management Impact of 68gallium-Tris(hydroxypyridinone) Prostate-Specific Membrane Antigen (68Ga-THP-Psma) PET-CT Imaging for High-Risk and Biochemically Recurrent Prostate Cancer

Related publications

Erratum To: Repeatability of [68Ga]DKFZ11-Psma PET Scans for Detecting Prostate-Specific Membrane Antigen-Positive Prostate Cancer

Impact of 68Ga-Psma-Pet/Ct on the Radiotherapeutic Approach for Prostate Cancer in Comparison to CT – A Retrospective Analysis

Mp36-02 Diagnostic Value of 68 Ga-Labelled Prostate-Specific Membrane Antigen (Psma) Pet/Ct Imaging for Renal Cell Carcinoma

PET Imaging of Prostate Cancer Xenografts With a Highly Specific Antibody Against the Prostate-Specific Membrane Antigen

68Ga-Psma Ligand PET/CT in Patients With Prostate Cancer: How We Review and Report

Comparison of 68Ga-Psma-11 PET/CT With 11c-Acetate PET/CT in Re-Staging of Prostate Cancer Relapse

Correction To: Randomized Prospective Phase III Trial of 68Ga-Psma-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]

Diagnostic Accuracy of 68Ga-Prostate-Specific Membrane Antigen (PSMA) Positron-Emission Tomography (PET) and Multiparametric (Mp)MRI to Detect Intermediate-Grade Intra-Prostatic Prostate Cancer Using Whole-Mount Pathology: Impact of the Addition of 68Ga-P

Diagnostic Performance of 68Ga-Psma-11 (HBED-CC) PET/CT in Patients With Recurrent Prostate Cancer: Evaluation in 1007 Patients